Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone

Andrologia

Volumn 43, Issue 5, 2011, Pages 293-296

  Garcia, J A ^a   Sanchez, P E ^a   Fraile, C ^b   Escovar, P ^a  

^a Cirujano Urólogo Instituto Docente de Urología   (Venezuela)

^b Carabobo University   (Venezuela)

Author keywords

Erectile dysfunction; Metabolic syndrome; Phosphodiesterase type 5 inhibitors; Sexual desire; Testosterone

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; ERECTILE DYSFUNCTION; HUMAN; HYPOGONADISM; MALE; METABOLIC SYNDROME X;

ADULT; AGED; ERECTILE DYSFUNCTION; HUMANS; HYPOGONADISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; TESTOSTERONE;

EID: 80053205779     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2009.00991.x     Document Type: Article

References (26)

1. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A (2003) Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf) 58:632-638.
2. Bancroft J (2005) The endocrinology of sexual arousal. J Endocrinol 186:411-427.
3. Buvat J, Bou Jaoudé G (2008) Combination therapy with phosphodiesterase type V inhibitors and testosterone. Curr Sex Health Rep 5:135-140.
4. Fagelman E, Fagelman A, Shabsigh R (2001) Efficacy, safety, and use of sildenafil in urologic practice. Urology 57:1141-1144.
5. Gooren LJ, Saad F (2006) Recent insights into androgen action on the anatomical and physiological substrate of penile erection. Asian J Androl 8:3-9.
6. Greenstein A, Mabjeesh NJ, Sofer M, Kaver I, Matzkin H, Chen J (2005) Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? J Urol 173:530-532.
7. Hwang TI, Chen HE, Tsai TF, Lin YC (2006) Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone. Int J Impot Res 18:400-404.
8. Jockenhovel F, Minnemann T, Schubert M, Freude S, Hubler D, Schumann C, Christoph A, Ernst M (2009) Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men. Eur J Endocrinol 160:815-819.
9. Kurbatov D, Kuznetsky J, Traish A (2008) Testosterone improves erectile function in hypogonadal patients with venous leakage. J Androl 29:630-637.
10. McMahon CG (2002) High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction. Int J Impot Res 14:533-538.
11. McMahon CN, Smith CJ, Shabsigh R (2006) Treating erectile dysfunction when PDE5 inhibitors fail. BMJ 332:589-592.
12. Rochira V, Balestrieri A, Madeo B, Granata AR, Carani C (2006) Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections. J Androl 27:165-175.
13. Saad F, Grahl AS, Aversa A, Yassin AA, Kadioglu A, Moncada I, Eardley I (2007a) Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction. BJU Int 99:988-992.
14. Saad F, Kamischke A, Yassin A, Zitzmann M, Schubert M, Jockenhel F, Behre HM, Gooren L, Nieschlag E (2007b) More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate. Asian J Androl 99:291-297.
15. Shabsigh R (2004) Testosterone therapy in erectile dysfunction. Aging Male 7:312-318.
16. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H (2004) Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172:658-663.
17. Shabsigh R, Perelman MA, Lockhart DC, Lue TF, Broderick GA (2005) Health issues of men: prevalence and correlates of erectile dysfunction. J Urol 174:662-667.
18. Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M (2008a) Sexual health as a portal to men's health: a problem turned around into an opportunity. Int J Clin Pract 62:179-181.
19. Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M (2008b) The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract 62:791-798.
20. Shamloul R, Ghanem H, Fahmy I, El-Meleigy A, Ashoor S, Elnashaar A, Kamel I (2005) Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study. J Sex Med 2:559-564.
21. Traish AM, Guay AT (2006) Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 3:382-404. Discussion 404-387
22. Traish A, Kim N (2005) The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J Sex Med 2:759-770.
23. Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I (1999) Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 140:1861-1868.
24. Traish AM, Goldstein I, Kim NN (2007) Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 52:54-70.
25. Yassin ASF (2005) Changes in penile cavernosography and venous leakage under testosterone treatment in hypogonadal patients with ED. Case report. Int J Androl 28:53.
26. Yassin AA, Saad F, Gooren LJ (2008) Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone. Andrologia 40:259-264.